Pharmaceuticals News

NEW YORK, April 24, 2026 (GLOBE NEWSWIRE) -- Plopii, a Brooklyn-based biotechnology company specializing in consumer wellness products and drug patent development centered on paraxanthine,...

Sanofi place 2,3 milliard d’euros d’emprunts obligataires  Paris, 24 avril 2026 - Sanofi annonce avoir placé avec succès une émission obligataire en 3 tranches (les « obligations ») pour un montant...

Sanofi successfully prices 2.3 billion of bond issue   Paris, April 24, 2026 - Sanofi announces that it has successfully priced its offering of €2.3 billion of notes across 3 tranches:  €1,000...

Goedkeuring van het dividendGereglementeerde informatie - 24 april 2026 De algemene vergadering van aandeelhouders van 24 april 2026 heeft de jaarrekening afgesloten op 31 december 2025, met inbegrip...

Approbation du dividendeInformation réglementée - 24 avril 2026 L’assemblée générale des actionnaires du 24 avril 2026 a approuvé les comptes annuels relatifs à l’exercice social clôturé le 31...

Dividend confirmationRegulated information - 24 April 2026 The general shareholders meeting of 24 April 2026 has approved the annual accounts as at 31 December 2025, including the distribution of a...

A collaboration with Virginia Tech supports recognizing remission as a treatment outcome—capturing symptoms, quality of life, and functional outcomes—beyond abstinence aloneOf all MOUD, monthly...

GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

Oslo, Norway, 24 April 2026 Please find attached the Annual Report for 2025 for Vistin Pharma ASA (VISTN). There is no material changes in the financial statement compared to the preliminary full...

A.D.A.M. Innovations Unveils GeneLock™ The World’s First Genetic Data Protection Platform